The low-dose dexamethasone suppression test in fibromyalgia

Katja Wingenfeld, Dieter Wagner, Iris Schmidt, Gunther Meinlschmidt, Dirk H. Hellhammer, Christine Marcelle Heim

Research output: Contribution to journalArticle

56 Scopus citations

Abstract

Objective: Fibromyalgia syndrome (FMS) has been associated with decreased cortisol secretion. Patients with posttraumatic stress disorder (PTSD) exhibit similar hypocortisolism in the context of increased negative feedback sensitivity of the hypothalamic-pituitary-adrenal (HPA) axis. Because trauma and PTSD have been associated with fibromyalgia, we evaluated whether patients with fibromyalgia demonstrate increased HPA feedback sensitivity. Method: Baseline blood samples were obtained at 0800 h, and 0.5 mg of dexamethasone was administered to 15 female patients with FMS and 20 normal controls at 2300 h. Adrenocorticotropin (ACTH), cortisol, and dexamethasone levels were measured at 0800 h after dexamethasone intake. Results: There were no group differences in mean ACTH or cortisol levels or in ACTH/cortisol ratio at baseline. After dexamethasone intake, patients with FMS exhibited more pronounced suppression of cortisol but not of ACTH, as well as increased ACTH/cortisol ratios compared with controls. Percent cortisol suppression was associated with pain and fatigue, while ACTH/cortisol ratio and dexamethasone availability were associated with stress and anxiety measures. Conclusion: Our results suggest increased sensitivity to glucocorticoid feedback, manifested at the adrenal level, in FMS.

Original languageEnglish (US)
Pages (from-to)85-91
Number of pages7
JournalJournal of Psychosomatic Research
Volume62
Issue number1
DOIs
StatePublished - Jan 1 2007

All Science Journal Classification (ASJC) codes

  • Clinical Psychology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'The low-dose dexamethasone suppression test in fibromyalgia'. Together they form a unique fingerprint.

  • Cite this